A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy

BJU International

Volumn 95, Issue 3, 2005, Pages 359-365

  Gontero, Paolo ^a   Fontana, Francesco ^a   Zitella, Andrea ^b   Montorsi, Francesco ^c   Frea, Bruno ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Erectile dysfunction; Intracavernosal injections; Oral treatment; Radical prostatectomy; Vacuum pump

Indexed keywords

APOMORPHINE; PROSTAGLANDIN E; SILDENAFIL;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; DEVICE; DRUG EFFICACY; DRUG RESPONSE; ERECTILE DYSFUNCTION; FOLLOW UP; HEADACHE; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NON NERVE SPARING RADICAL PROSTATECTOMY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT COUNSELING; PENIS ERECTION; PENIS PROSTHESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATECTOMY; QUESTIONNAIRE; SCORING SYSTEM; TREATMENT FAILURE; VACUUM; VOMITING;

ADMINISTRATION, SUBLINGUAL; AGED; ALGORITHMS; APOMORPHINE; FOLLOW-UP STUDIES; HUMANS; IMPOTENCE; MALE; PATIENT COMPLIANCE; PENILE PROSTHESIS; PIPERAZINES; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTAGLANDINS E; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME; VACUUM; VASODILATOR AGENTS;

EID: 14144256446     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05300.x     Document Type: Article

References (24)

1. The CaPSURE Investigators. The contemporary management of prostate cancer in the united states: lessons from the Cancer of the Prostate Strategic Urologic Research Endeavour (CAPSURE), a national disease registry. J Urol 2004; 171: 1393-401
2. Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983; 4: 473-85
3. Sachs BD, Liu YC. Maintenance of erection of penile glans, but not penile body, after transection of rat cavernous nerves. J Urol 1991; 146: 900-5
4. Penson DF, Feng Z, Kuniyuri A et al. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcome study. J Clin Oncol 2003; 21: 1147-54
5. Gralnek D, Wessells H, Cui H, Dalkin BL. Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy. J Urol 2000; 163: 1166-8
6. Baniel J, Israilov S, Segenreich E, Livne PM. Comparative evaluation of treatments for erectile dysfunction in patients with prostate cancer after radical retropubic prostatectomy. BJU Int 2001; 88: 58-61
7. Zagaja GP, Mhoon DA, Aikens JE, Brendler CB. Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology 2000; 56: 631-4
8. Zippe CD, Jhaveri FM, Klein EA et al. Role of Viagra after radical prostatectomy. Urology 2000; 55: 241-5
9. Dennis RL, McDougal WS. Pharmacological treatment of erectile dysfunction after radical prostatectomy. J Urol 1988; 139: 775-9
10. Wespes E, Amar E, Hatzichristou D, Montorsi F, Pryor J, Vardi Y. European Association of Urology. Guidelines on erectile dysfunction. Eur Urol 2002; 41: 1-5
11. Rosen RC, Riley A, Wagner G. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-6
12. Cappellieri JC. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999; 54: 346-9
13. Gontero P, Fontana F, Bagnasacco A et al. Is there an optimal timing for intracavernous PGE1 rehabilitation following nonnerve sparing radical prostatectomy? Results from an hemodynamic perspective study. J Urol 2003; 169: 2166-9
14. Virag R, Frydman D, Legman M, Virag H. Intracavernous injection of papaverine as diagnostic and therapeutic method in erectile failure. Angiology 1984; 35: 79-81
15. Wong D, Whaley L. Clinical Manual of Pediatric Nursing. St. Louis: Mosby-Year Book, 1990
16. Perez MA, Meyerowitz BE, Lieskovsky G, Skinner DG, Reynolds B, Skinner EC. Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile aids. Urology 1997; 50: 740-6
17. Zippe CD, Raina R, Thukral M, Lakin MM, Klein EA, Agarwal A. Management of erectile dysfunction following radical prostatectomy. Current Urol Rep 2001; 2: 495-503
18. Heaton JP, Adams MA, Morales A. A therapeutic taxonomy of treatments for erectile dysfunction: an evolutionary perspective. Int J Imp Res 1997; 9: 115-21
19. Stief C, Padley RJ, Perdok RJ, Sleep DJ. Cross-study review of the clinical efficacy of Apomorphine SL 2 and 3 mg: pooled data from three placebo-controlled, fixed-dose crossover studies. Eur Urol 2002; 1 (Suppl): 12-20
20. McCullough AR. Prevention and management of erectile dysfunction following radical prostatectomy. Urol Clin North Am 2001; 28: 613-27
21. Dennis RL, McDougal WS. Pharmacological treatment of erectile dysfunction after radical prostatectomy. J Urol 1987; 139: 775-6
22. Soderdhal DW, Thrasher JB, Hansberry KL Intracavernosal drug-induced erection therapy versus external vacuum devices in the treatment of erectile dysfunction. Br J Urol 1997; 79: 952-7
23. Raina R, Lakin MM, Thukral M et al. Long-term efficacy and compliance of intracorporeal (IC) injections for erectile dysfunction following radical prostatectomy. SHIM (IIEF-5) analysis. Int J Imp Res 2003; 15: 318-22
24. Rajpurkar A, Dhabuwala CB. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice. J Urol 2003; 170: 159-63